SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-13-062317
Filing Date
2013-08-09
Accepted
2013-08-09 16:02:56
Documents
2
Group Members
BRGO CORP

Document Format Files

Seq Description Document Type Size
1 SC 13D a13-18362_1sc13d.htm SC 13D 111599
2 EX-1 a13-18362_1ex1.htm EX-1 114315
  Complete submission text file 0001104659-13-062317.txt   227454
Mailing Address 65 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE LEXINGTON MA 02421 781-860-8660
CUBIST PHARMACEUTICALS INC (Filed by) CIK: 0000912183 (see all company filings)

IRS No.: 223192085 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Subject) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85614 | Film No.: 131026518
SIC: 2834 Pharmaceutical Preparations